2025 · 3rd Quarter (July 1 - Sep 30)

ASSOCIATION FOR ACCESSIBLE MEDICINES

Filed by THE GIBSON GROUP, LLC.

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 13, 2025
Income: $30,000.00
Expenses: Not reported
Registrant: THE GIBSON GROUP, LLC
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES
Filing UUID: e8d9d966-e52f-4525-8736-43adee6993ef
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Drug competition issues Monitor drug supply chain issues

LBR · Labor Issues/Antitrust/Workplace

Drug competition issues

CPT · Copyright/Patent/Trademark

Monitor S 1096 - patent settlements Monitor issues relating to review of pharmaceutical patents in inter partes reviews Monitor issues relating to the Patent Trial and Appeal Board Patent thickets - S. 1041 Monitor S. 1040 - product hopping Skinny labeling issues Monitor issues relating to the Patent Eligibility Restoration Act Monitor issues relating to the PREVAIL Act

Literal federal measure citations: S 1096, S. 1041, S. 1040

TRD · Trade (domestic/foreign)

Monitor issues related to trade agreeements

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.